BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16439706)

  • 1. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
    Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
    Matsui R; Xu S; Maitland KA; Hayes A; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Circulation; 2005 Jul; 112(2):257-63. PubMed ID: 15998684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice.
    Palombo F; Shen H; Benguigui LE; Kazarian SG; Upmacis RK
    Analyst; 2009 Jun; 134(6):1107-18. PubMed ID: 19475136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
    Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
    Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S; Laury-Kleintop L; Lanza-Jacoby S
    J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
    Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of polygoni multiflori total glycosides on the experimentally atherosclerotic formation in apoE-deficient mice].
    Fang W; Zhang HX; Wang LY; Wu Y; Qin YW; Wang W; Du LP; Lu B
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(19):1542-5. PubMed ID: 16335829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
    Fabrizio Rodella L; Bonomini F; Rezzani R; Tengattini S; Hayek T; Aviram M; Keidar S; Coleman R; Bianchi R
    Acta Histochem; 2007; 109(1):45-51. PubMed ID: 17046051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C; Gomez M; Calvo E; López JA; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):27-32. PubMed ID: 18988893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.